Insights for action

In the face of political gridlock and legislative uncertainty, the way forward for life sciences and health care companies can be unclear. We partner with leaders and innovators to provide strategic advice as they navigate the evolving regulatory, funding, political, and policy landscapes to create roadmaps for growth in unprecedented times.

In this environment, collaborating with strategic, invested partners who anticipate challenges and opportunities now and down the road is critical to your resiliency and success. We combine political intelligence, sector insights, and a nuanced understanding of market conditions and risk with a powerful global platform to deliver solutions that put policy on your side wherever you do business.

With 30 years of experience building coalitions and driving bipartisan progress on Capitol Hill, our team has built a reputation for knowing how to get things done on both sides of the aisle. We know the process and key players, and how to collaboratively cut through gridlock and competing priorities.

We bring unmatched legislative experience that includes developing and advancing critical legislation for the lifecycle of 21st century health care delivery – from research and development to approval and coverage of medical products. Our team has driven improvements to our nation’s medical preparedness and response systems, all with an eye on understanding and building pathways to address the workforce needs for the future.

“They offer guidance and insight every step of the way, have always put the company’s best interest first, and serve as a strong and respected advocate for us.”

Chambers USA 2021 Healthcare

Our experience also includes creating, reforming, overseeing, and collaborating with key US public health and regulatory agencies such as the Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Administration for Strategic Preparedness and Response (ASPR), and the Biomedical Advanced Research and Development Authority (BARDA). No other team can offer equivalent capabilities with respect to the federal agencies at the center of the American health care system. Now, we apply the very expertise that has helped shape this system for decades to the needs of our clients.

From in-depth business analysis and strategic planning to legislative and advocacy policy proposals, our multi-disciplinary solutions identify strategic opportunities and reduce potential vulnerabilities. And at the intersection of investment and national interest, our forward-looking approach balances shifting policy, political, and financial dynamics to help advance your business objectives now and in the future.

Complementary Capabilities

DLA Piper’s Health Policy Strategic Consulting Practice is part of a unique combined legal, regulatory, and policy offering, unmatched in either the legal services or consulting sectors. The Strategic Consulting Practice is complimented by DLA Piper’s leading practices in Life Sciences Regulatory, Healthcare Regulatory and FDA Regulatory.

Awards and recognition



At the Intersection of Science and Law